6-154247041-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001130700.2(IPCEF1):​c.77-281C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.376 in 409,484 control chromosomes in the GnomAD database, including 30,483 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10478 hom., cov: 31)
Exomes 𝑓: 0.38 ( 20005 hom. )

Consequence

IPCEF1
NM_001130700.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.01

Publications

4 publications found
Variant links:
Genes affected
IPCEF1 (HGNC:21204): (interaction protein for cytohesin exchange factors 1) Predicted to enable peroxidase activity. Predicted to be involved in response to oxidative stress. Predicted to be located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
OPRM1 (HGNC:8156): (opioid receptor mu 1) This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.414 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IPCEF1NM_001130700.2 linkc.77-281C>G intron_variant Intron 4 of 11 ENST00000367220.9 NP_001124172.1 Q8WWN9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IPCEF1ENST00000367220.9 linkc.77-281C>G intron_variant Intron 4 of 11 2 NM_001130700.2 ENSP00000356189.4 Q8WWN9-2
ENSG00000288520ENST00000673182.1 linkc.1460-281C>G intron_variant Intron 14 of 21 ENSP00000499846.1

Frequencies

GnomAD3 genomes
AF:
0.365
AC:
55244
AN:
151544
Hom.:
10481
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.295
Gnomad AMI
AF:
0.418
Gnomad AMR
AF:
0.298
Gnomad ASJ
AF:
0.553
Gnomad EAS
AF:
0.277
Gnomad SAS
AF:
0.226
Gnomad FIN
AF:
0.417
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.419
Gnomad OTH
AF:
0.381
GnomAD4 exome
AF:
0.383
AC:
98847
AN:
257838
Hom.:
20005
Cov.:
4
AF XY:
0.381
AC XY:
50377
AN XY:
132136
show subpopulations
African (AFR)
AF:
0.291
AC:
2439
AN:
8370
American (AMR)
AF:
0.259
AC:
2611
AN:
10084
Ashkenazi Jewish (ASJ)
AF:
0.529
AC:
4749
AN:
8984
East Asian (EAS)
AF:
0.249
AC:
5312
AN:
21328
South Asian (SAS)
AF:
0.214
AC:
2753
AN:
12856
European-Finnish (FIN)
AF:
0.416
AC:
7025
AN:
16878
Middle Eastern (MID)
AF:
0.426
AC:
509
AN:
1194
European-Non Finnish (NFE)
AF:
0.415
AC:
67066
AN:
161762
Other (OTH)
AF:
0.390
AC:
6383
AN:
16382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
2708
5416
8123
10831
13539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.364
AC:
55250
AN:
151646
Hom.:
10478
Cov.:
31
AF XY:
0.361
AC XY:
26728
AN XY:
74084
show subpopulations
African (AFR)
AF:
0.295
AC:
12177
AN:
41320
American (AMR)
AF:
0.298
AC:
4534
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.553
AC:
1918
AN:
3468
East Asian (EAS)
AF:
0.277
AC:
1434
AN:
5170
South Asian (SAS)
AF:
0.227
AC:
1090
AN:
4812
European-Finnish (FIN)
AF:
0.417
AC:
4354
AN:
10430
Middle Eastern (MID)
AF:
0.473
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
0.419
AC:
28425
AN:
67914
Other (OTH)
AF:
0.380
AC:
798
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1722
3444
5166
6888
8610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.383
Hom.:
1474
Bravo
AF:
0.359
Asia WGS
AF:
0.242
AC:
843
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
11
DANN
Benign
0.80
PhyloP100
1.0
PromoterAI
0.088
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9322453; hg19: chr6-154568175; COSMIC: COSV54550625; COSMIC: COSV54550625; API